Blinatumomab 9ug

DRUG2 trials

Sponsors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Mao Jianhua

Conditions

Acute Lymphoblastic LeukemiaB-cell Non Hodgkin LymphomaBlinatumomabChildrenPre B-Cell Acute Lymphoblastic LeukaemiaSystemic Lupus Erythematosus (SLE)

Phase 1

A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance

Active, not recruitingNCT03114865

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsAcute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma, Pre B-Cell Acute Lymphoblastic Leukaemia

Start: 2017-09-05End: 2026-10-30Updated: 2026-07-06

Blinatumomab in Refractory Active Childhood Systemic Lupus Erythematosus

RecruitingNCT06789107

Mao JianhuaBlinatumomab, Children, Systemic Lupus Erythematosus (SLE)

Start: 2024-12-08End: 2027-12-07Target: 6Updated: 2025-11-28